:: Class Utilisation Summary 2015
See LEGEND for key to shading and symbols.
:: Subject Area - OPTM Term - Semester 2
OPTM0001 | OPTM0002 | OPTM2291 | OPTM3211 | OPTM3231 | OPTM4211 |
OPTM4231 | OPTM4251 | OPTM4271 | OPTM5211 | OPTM5231 | OPTM5251 |
OPTM5271 | OPTM7001 | OPTM7003 | OPTM7007 | OPTM7104 | OPTM7108 |
OPTM7205 | OPTM7308 | OPTM7511 |
Data is correct as at Mon Oct 5 19:07:29 AEDT 2015
Comp | Sect | Class | Type | Status | Enr/Cap | % Full | Times (weeks, Location) - default 1hour |
OPTM0001 | Research Thesis Optometry F/T | ||||||
THE | 0001 | 1337 | Enr | Open | 30/2000 | 2% | |
OPTM0002 | Research Thesis Optometry P/T | ||||||
THE | 0001 | 1338 | Enr | Open | 9/2000 | 0% | |
OPTM2291 | Primary Care Optometry | ||||||
LAB | GP1 | 7715 | Enr | Full | 24/24 | 100% | Mon 09-11 (w2-9,10-13, Myers 2009); Thu 08 (w10-13, Myers 2009); Thu 12-14 (w2-9,10-13, Myers 2009) |
LAB | GP2 | 7716 | Enr | Open | 20/24 | 83% | Tue 08 (w10-13, Myers 2009); Tue 12-14 (w2-9,10-13, Myers 2009); Fri 09-11 (w2-9,10-13, Myers 2009) |
LAB | GP3 | 7717 | Enr | Open | 13/24 | 54% | Wed 08 (w10-13, Myers 2009); Wed 10-12 (w2-9,10-13, Myers 2009); Thu 16-18 (w2-9,10-13, Myers 2009) |
LAB | GP4 | 7718 | Enr | Open | 20/24 | 83% | Wed 12-14 (w2-9,10-13, Myers 2009); Thu 14-16 (w2-9,10-13, Myers 2009); Fri 08 (w10-13, Myers 2009) |
LEC | A | 7713 | Rel | Open | 77/96 | 80% | Mon 11 (w1-9,10-12, ChemSc M11); Fri 11 (w1-3,5-9,10-12, Ainswth202); Fri 11 (w4, Ainswth202) |
OTH | H09A | 7714 | Rel | Open | 77/96 | 80% | Thu 09-12 (Myers 2009) |
OPTM3211 | Optometry 3B | ||||||
LA1 | GP1 | 4732 | Enr | Stop | 21/24 | 88% | Mon 10-13 (w1-9,11-13, See School); Tue 08-10 (w7-9, Myers 2009) |
LA1 | GP2 | 4733 | Enr | Stop | 19/24 | 79% | Mon 10-13 (w1-9,11-13, See School); Wed 14-16 (w7-9, Myers 2009) |
LA1 | GP3 | 4734 | Enr | Stop | 16/24 | 67% | Tue 13-16 (w1-9,11-13, See School); Wed 08-10 (w7-9, Myers 2009) |
LA1 | GP4 | 4735 | Enr | Stop | 24/24 | 100% | Tue 13-16 (w1-9,11-13, See School); Fri 15-17 (w7-9, Myers 2009) |
LA2 | AQUA | 4736 | Rel | Stop | 11/11 | 100% | Tue 12 (w2-9,10-13, Myers 3016) |
LA2 | BLUE | 4737 | Rel | Stop | 7/11 | 64% | Tue 13 (w2-9,10-13, Myers 3016) |
LA2 | GREE | 4738 | Rel | Stop | 11/11 | 100% | Wed 10 (w2-9,10-13, Myers 3016) |
LA2 | GREY | 4739 | Rel | Canc | 0/11 | 0% | Wed 09 (w2-9,10-13) |
LA2 | ORAN | 4740 | Rel | Stop | 10/11 | 91% | Wed 11 (w2-9,10-13, Myers 3016) |
LA2 | PURP | 4741 | Rel | Stop | 11/11 | 100% | Fri 12 (w2-9,10-13, Myers 3016) |
LA2 | RED | 4742 | Rel | Stop | 8/11 | 73% | Tue 09 (w2-9,10-13, Myers 3016) |
LA2 | TAN | 4743 | Rel | Stop | 11/11 | 100% | Thu 09 (w2-9,10-13, Myers 3016) |
LA2 | VIOL | 4744 | Rel | Stop | 11/11 | 100% | Thu 10 (w2-9,10-13, Myers 3016) |
LEC | A | 4731 | Rel | Open | 80/96 | 83% | Thu 11 (w1-9,10-12, CivEng 101); Fri 10-12 (w1-9,10, ChemSc M11); Fri 10-12 (w11, ChemSc M11); Fri 10-12 (w12, ChemSc M11) |
OPTM3231 | Ocular Disease 3B | ||||||
LE1 | M15A | 4745 | Enr | Open | 95/114 | 83% | Mon 15-17 (w2-9,10-13, MacauleyTh); Tue 16-18 (w2-9,10-13, MacauleyTh) |
LE2 | H12A | 4746 | Rel | Open | 95/114 | 83% | Thu 12 (w2-9,10-13, RC Theatre) |
OPTM4211 | Optometry 4B | ||||||
LA1 | M11A | 4748 | Enr | Open | 18/24 | 75% | Mon 11-13 (w2-4,8,10-11, Myers 2009); Mon 11-13 (w5-7,9,12-13, Myers 2009) |
LA1 | T10A | 4749 | Enr | Open | 18/24 | 75% | Tue 10-12 (w2-4,8,10-11, Myers 2009); Tue 10-12 (w5-7,9,12-13, Myers 2009) |
LA1 | W16A | 4750 | Enr | Open | 13/18 | 72% | Wed 16-18 (w2-4,8,11-12, Myers 2009) |
LA2 | T12A | 4751 | Rel | Full | 24/24 | 100% | Tue 12-14 (w3-4,5, OMB G25) |
LA2 | T12B | 4752 | Rel | Full | 25/24 | > 100% | Tue 12-14 (w6-7,8, OMB G25) |
LEC | A | 4747 | Rel | Full | 49/48 | > 100% | Tue 16-18 (w1-3,6-9,10-12, BUS 220); Tue 16-18 (w4-5, BUS 220); Thu 16 (w1-4, Myers Thtr); Thu 16 (w5-9,10-12, Myers Thtr); Thu 17 (w1-4, Myers Thtr); Thu 17 (w5-9,10-12, Myers Thtr); Fri 09-11 (w1-2, TETB LG05) |
OPTM4231 | Clinical Optometry 4B | ||||||
LEC | A | 4758 | Enr | Full | 48/48 | 100% | Fri 11 (w2-9,10-13, Myers Thtr) |
OPTM4251 | Ocular Therapeutics 4B | ||||||
LAB | 501 | 4754 | Enr | Open | 16/18 | 89% | Mon 11-13 (w7,9,11-13, OPTM CL) |
LAB | 502 | 4755 | Enr | Open | 15/18 | 83% | Wed 14-16 (w7,9,11-13, OPTM CL) |
LAB | 503 | 4756 | Enr | Open | 16/18 | 89% | Fri 15-17 (w7,9,11-13, OPTM CL) |
LEC | A | 4753 | Rel | Open | 47/48 | 98% | Mon 09-11 (w2-3,6, OMB 150); Mon 09-11 (w4-5,7-9,10-13, OMB 150); Mon 16 (w2-3,6, Quad G031); Mon 16 (w4-5,7-9,10-13, Quad G031); Fri 09-11 (w5,7,9,10-13, OMB 150) |
LEC | B | 9949 | Rel | Closed | 0/48 | 0% | Fri 09-11 (w5,7,9,10-13) |
TUT | 504 | 4757 | Rel | Open | 47/48 | 98% | Fri 09-11 (w3-4,6,8, Mat 113) |
OPTM4271 | Professional Optometry | ||||||
LEC | A | 6455 | Enr | Full | 48/48 | 100% | Mon 14-16 (w2-9,10-13, Myers Thtr); Thu 14-16 (w2-9,10-13, Myers Thtr) |
OPTM5211 | Clinical Optometry 5B | ||||||
LEC | A | 4759 | Enr | Full | 75/75 | 100% | Mon 17 (w2-9,10-13, Myers Thtr); Fri 13 (w2-9,10-13, Myers Thtr) |
OPTM5231 | Specialist Clinical Optom 5B | ||||||
TUT | A | 4760 | Enr | Full | 75/75 | 100% | Tue 15:30 (w2-9,10-13, Myers Thtr) |
OPTM5251 | Clinical Ocular Therap 5B | ||||||
CLN | 001 | 9734 | Enr | Full | 75/75 | 100% | |
OPTM5271 | Research Project 5B | ||||||
OTH | 001 | 9735 | Enr | Full | 75/75 | 100% | |
OPTM7001 | Intro to Community Eye Health | ||||||
LEC | 001 | 9899 | Enr | Open | 6/20 | 30% | |
OPTM7003 | Epid of Blinding Eye Diseases | ||||||
LEC | 001 | 9900 | Enr | Open | 11/20 | 55% | |
OPTM7007 | Community Eye Health Project | ||||||
LEC | 001 | 9901 | Enr | Open | 0/20 | 0% | |
OPTM7104 | Adv. Contact Lens Studies 1 | ||||||
LEC | 001 | 10207 | Enr | Open* | 12/30 | 40% | |
OPTM7108 | Research Skills in Optometry | ||||||
LEC | 001 | 9902 | Enr | Open | 3/30 | 10% | |
OPTM7205 | Specialty Contact Lens Studies | ||||||
LEC | 001 | 9903 | Enr | Open | 6/20 | 30% | |
OPTM7308 | Research Project | ||||||
LEC | 001 | 9904 | Enr | Open | 6/30 | 20% | |
OPTM7511 | Advanced Ocular Disease 1 | ||||||
LEC | 001 | 9905 | Enr | Open | 10/20 | 50% | |
^ top ^ | |||||||
LEGEND | |||||||
* This class requires consent. Students cannot self-enrol. | |||||||
# Timetable clash allowed. | |||||||
/odd Runs in odd weeks only. /even Runs in even weeks only. | |||||||
Comb/w Jointly taught with corresponding class(es) for specified course(s). Capacity shown is effective capacity. | |||||||
Effective capacity is the class capacity less any places taken by students in the other jointly-taught classes. | |||||||
[ ] Class capacity where different from effective capacity. | |||||||
Shaded cells: | LEC | Activity different from previous | |||||
Stop | Status is Stop Further Enrolment, Tentative, Closed or Cancelled | ||||||
100% | Class is full (> 100% means capacity is exceeded) | ||||||
80% | Class is nearly full (80% or more) | ||||||
50% | Class is half full | ||||||
0% | Class is less than half full | ||||||
UNSW Sydney NSW 2052, Australian Telephone: (within Aust) 02 9385 1000, (International) +61 2 9385 1000 CRICOS Provider Code 00098G Authorised by Deputy Vice Chancellor (Academic) & Registrar Privacy Statement Copyright & Disclaimer |